GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (AQSE:ORPH) » Definitions » Net Interest Income

hVIVO (AQSE:ORPH) Net Interest Income : £0.77 Mil (TTM As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is hVIVO Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. hVIVO's net interest income for the six months ended in Jun. 2024 was £0.29 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2024 was £0.77 Mil.

hVIVO Net Interest Income Historical Data

The historical data trend for hVIVO's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

hVIVO Net Interest Income Chart

hVIVO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.35 -0.37 -0.22 - 1.01

hVIVO Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 0.18 0.53 0.48 0.29

hVIVO Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

hVIVO Net Interest Income Related Terms

Thank you for viewing the detailed overview of hVIVO's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

hVIVO Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (AQSE:ORPH) » Definitions » Net Interest Income
Comparable Companies
LSE:ARIX LSE:SCLP LSE:FUM LSE:REDX LSE:FARN LSE:OBD LSE:BVXP LSE:4BB LSE:ETX LSE:AREC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
OPORF:USA HVO:UK CRO:Germany
Address
42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX
Website
https://www.hvivo.com
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO Headlines

No Headlines